Susquehanna Fundamental Investments, LLC Verastem, Inc. Transaction History

Susquehanna Fundamental Investments, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.92 - $11.16 $174,150 - $2.11 Million	-189,294 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$2.05 - $3.2 $145,445 - $227,036	-70,949 Reduced 27.26%	189,294 $388,000
Q3 2021 Nov 15, 2021	BUY	$2.54 - $4.07 $610,979 - $979,010	240,543 Added 1221.03%	260,243 $802,000
Q2 2021 Aug 11, 2021	BUY	$2.57 - $4.85 $50,629 - $95,545	19,700 New	19,700 $80,000

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $880M
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.